Polypeptide’s potential application in the research and development of new pharmaceuticals has fueled its demand over the years. Synthetically produced polypeptides are increasingly used in drugs because they are simple and inexpensive to make, and they also improve the function of natural polypeptides in the body.
Polypeptide also aids in the improvement of immune function and hormone production. These are the most important factors influencing the growth of the polypeptide market. Polypeptide use has changed over time and continues to change as newer changes in drug development and treatment methods emerge. Furthermore, the growing scope of application in cosmetics and personal care products is expected to propel the polypeptide market forward.
Polypeptide Market to be Boosted by Applications in Chemotherapeutic Medicines and Anti-Cancer Pharmaceuticals
With the rising number of cancer patients, many pharmaceutical companies are investing heavily in research to find effective anti-cancer drugs. Cancer was the second leading cause of death worldwide, according to the World Health Organization (WHO), killing over 8.8 million people.
Patients in low- and middle-income countries who are diagnosed with cancer die in 70% of cases. It creates a demand for effective oncology medicine that can reduce the number of cancer-related deaths. Polypeptides are widely used in cancer treatments, particularly hormone-dependent cancers, due to their chemical structure, which is the primary factor driving the polypeptide market’s growth.
According to the National Cancer Institute, more than 1.73 million new cancer cases will be diagnosed in 2018. It also predicts that by the end of 2018, cancer will have killed over 609,640 people in the United States. Because conventional chemotherapeutic medicines have limitations, a growing number of pharmaceutical companies are turning to polypeptides to develop cancer therapies. The growth of the polypeptide market is being fueled by the increased effectiveness of oncology medicines made with polypeptides.
Polypeptides’ Industrial Applications are Expanding Due to Technological Advancements
The demand for polypeptides in biotechnological and pharmaceutical applications is expected to remain high, depending on the length of clinical trials and new potential leads in genomics. Its expanding applications in the biomedical industry are helping to drive the polypeptide market forward. The enormous interest of pharmaceutical manufacturers in antimicrobial peptides (AMPs), which play an important therapeutic role in wound healing or regeneration, is largely responsible for the polypeptide’s growth.
Polypeptides, when used in vaccines, provide complete protection against a variety of infectious diseases. Polypeptides’ chemical diversity and amino acid sequences are being used by manufacturers to control biological cellular functions and provide more effective biomedical solutions.
For List of Key Players and Full Segmentation, Ask for a Sample Report
